@prefix jvr: . @prefix mesh: . @prefix skos: . @prefix dc: . @prefix xsd: . @prefix owl: . jvr:-T9LDJ61T-L mesh:pharmacologicalAction jvr:-MSF3P3V1-C . jvr:-X1XN2T14-3 mesh:pharmacologicalAction jvr:-MSF3P3V1-C . jvr:-L6C0XPHT-4 skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-KL2KV4BL-H mesh:pharmacologicalAction jvr:-MSF3P3V1-C . jvr:-QNQ2JMZG-H mesh:pharmacologicalAction jvr:-MSF3P3V1-C . jvr:-WCRJL1ZH-1 mesh:pharmacologicalAction jvr:-MSF3P3V1-C . jvr:-FDWC4DKW-M mesh:pharmacologicalAction jvr:-MSF3P3V1-C . jvr:-CB5D99ZF-N mesh:pharmacologicalAction jvr:-MSF3P3V1-C . jvr:-RN0Q1HDQ-V mesh:pharmacologicalAction jvr:-MSF3P3V1-C . jvr:-TJWRD1F9-9 mesh:pharmacologicalAction jvr:-MSF3P3V1-C . jvr:-ZDX75RXF-X skos:prefLabel "Topoisomerase Inhibitors"@en, "Inhibiteurs des topoisomérases"@fr ; a mesh:Descriptor, skos:Concept ; skos:narrower jvr:-MSF3P3V1-C . jvr:-T9HQD7ST-J skos:prefLabel "ressources et distribution (Qualificatif)"@fr, "supply & distribution (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-NB0XHT3S-N skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-WFN9ZZ1D-1 mesh:pharmacologicalAction jvr:-MSF3P3V1-C . jvr:-W0N9180W-2 mesh:pharmacologicalAction jvr:-MSF3P3V1-C . jvr:-SSWSV1KV-Q mesh:pharmacologicalAction jvr:-MSF3P3V1-C . jvr:-BWQWHCBL-R mesh:pharmacologicalAction jvr:-MSF3P3V1-C . jvr: a skos:ConceptScheme . jvr:-XCC4XSDF-1 mesh:pharmacologicalAction jvr:-MSF3P3V1-C . jvr:-G30ZJ446-J skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-NKM836P1-M skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-W6SQV79N-S skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-H7K65Q8S-Z skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-R3QWLHRG-V skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-TZPJG2K9-3 mesh:pharmacologicalAction jvr:-MSF3P3V1-C . jvr:-KZPZVMR3-R mesh:pharmacologicalAction jvr:-MSF3P3V1-C . jvr:-S0CS1X5R-5 skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-CB30NGKB-3 skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-MSF3P3V1-C mesh:allowableQualifier jvr:-FWD2BGQ0-9, jvr:-T9HQD7ST-J, jvr:-L6C0XPHT-4, jvr:-BT300B3G-Q, jvr:-NFTHND7Q-8, jvr:-D0F21513-5, jvr:-W6SQV79N-S, jvr:-WK5F724J-1, jvr:-THHNVC7V-3, jvr:-G30ZJ446-J, jvr:-TJHVZCRZ-0, jvr:-NKM836P1-M, jvr:-HQRFT0C6-B, jvr:-H7K65Q8S-Z, jvr:-XV06LPML-W, jvr:-NB0XHT3S-N, jvr:-SBNWSM1T-R, jvr:-S0CS1X5R-5, jvr:-NHL3D2X0-S, jvr:-CB30NGKB-3, jvr:-Q3979798-W, jvr:-R3QWLHRG-V ; skos:hiddenLabel "DNA Gyrase Inhibitor"@en, "DNA Gyrase Inhibitors"@en ; a skos:Concept, mesh:Descriptor ; skos:altLabel "DNA Topoisomerase II Inhibitor"@en, "Inhibiteurs de l'ADN topoisomérase-2"@fr, "Inhibiteurs de l'ADN topoisomérase de type II"@fr, "Inhibiteurs de l'ADN topoisomérase-II"@fr, "DNA Topoisomerase II Inhibitors"@en, "Topoisomerase II Inhibitor"@en, "Inhibiteurs de l'ADN topoisomérase de type 2"@fr, "DNA Type 2 Topoisomerase Inhibitors"@en, "Topoisomerase 2 Inhibitors"@en, "Inhibiteurs de la topoisomérase-2"@fr ; skos:prefLabel "Inhibiteurs de la topoisomérase-II"@fr, "Topoisomerase II Inhibitors"@en ; skos:broader jvr:-ZDX75RXF-X ; dc:modified "2020-06-29"^^xsd:date ; dc:created "2010-06-25"^^xsd:date ; skos:definition "Compounds that inhibit the activity of DNA TOPOISOMERASE II. Included in this category are a variety of ANTINEOPLASTIC AGENTS which target the eukaryotic form of topoisomerase II and ANTIBACTERIAL AGENTS which target the prokaryotic form of topoisomerase II."@en ; owl:sameAs ; dc:established "2011-01-01"^^xsd:date ; skos:inScheme jvr: . jvr:-Q3979798-W skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-WN4RBMR3-B mesh:pharmacologicalAction jvr:-MSF3P3V1-C . jvr:-D0F21513-5 skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-WK5F724J-1 skos:prefLabel "pharmacokinetics (Qualifier)"@en, "pharmacocinétique (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-BT300B3G-Q skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-M2WMR90H-M mesh:pharmacologicalAction jvr:-MSF3P3V1-C . jvr:-C3RMRMWL-4 mesh:pharmacologicalAction jvr:-MSF3P3V1-C . jvr:-ZNMFTDMP-J mesh:pharmacologicalAction jvr:-MSF3P3V1-C . jvr:-GG3QT9H8-7 mesh:pharmacologicalAction jvr:-MSF3P3V1-C . jvr:-NFTHND7Q-8 skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-FWD2BGQ0-9 skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-THHNVC7V-3 skos:prefLabel "synthèse chimique (Qualificatif)"@fr, "chemical synthesis (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-NCNCWFJN-1 mesh:pharmacologicalAction jvr:-MSF3P3V1-C . jvr:-TJHVZCRZ-0 skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-XV06LPML-W skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-HQRFT0C6-B skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-NK91909R-K mesh:pharmacologicalAction jvr:-MSF3P3V1-C . jvr:-NHL3D2X0-S skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-SBNWSM1T-R skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept .